Skip Navigation

Cardiovascular Research 2000 45(3):560-569; doi:10.1016/S0008-6363(99)00372-7
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Feuerstein, G. Z.
Right arrow Articles by Young, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feuerstein, G. Z.
Right arrow Articles by Young, P. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Apoptosis in cardiac diseases: stress- and mitogen-activated signaling pathways

Giora Z. Feuerstein* and Peter R. Young

Cardiovascular Disease Research, DuPont Pharmaceuticals Corporation, Wilmington, DE 19880-0400, USA

* Corresponding author. Tel.: +1-302-695-1840; fax: +1-302-695-4162

Apoptosis is a form of cell death that involves discrete genetic and molecular programs, de novo protein expression and a unique cellular phenotype. Evidence for the existence of apoptosis in the human heart has been reported in various cardiac diseases, including ischemic and non-ischemic heart failure, myocardial infarction and arrhythmias. Among the most potent stimuli that elicit cardiomyocyte apoptosis are: oxygen radicals (including NO), cytokines (FAS/TNF{alpha}-receptor signaling), stress conditions (chemical or physical, e.g., radiation), sphingolipid metabolites (ceramide) and autocoids, e.g., angiotensin II. Apoptosis of cardiac myocytes may contribute to progressive pump-failure, arrhythmias and cardiac remodeling. The recognition of numerous molecular targets associated with cardiomyocyte apoptosis may provide novel therapeutic strategies for diverse cardiac ailments, as recently suggested by pharmacologic studies in experimental animals. This review paper is aimed to highlight the role of protein kinase signaling pathways in apoptosis with special attention to the stress-activated protein kinases (SAPK) and mitogen-activated protein kinases (MAPK) systems.

KEYWORDS Heart failure; Protein kinases; Signal transduction


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. Ares-Carrasco, B. Picatoste, A. Benito-Martin, I. Zubiri, A. B. Sanz, M. D. Sanchez-Nino, A. Ortiz, J. Egido, J. Tunon, and O. Lorenzo
Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes
Am J Physiol Heart Circ Physiol, December 1, 2009; 297(6): H2109 - H2119.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Pramanik, C. Z. Chun, M. K. Garnaas, G. V. Samant, K. Li, M. A. Horswill, P. E. North, and R. Ramchandran
Dusp-5 and Snrk-1 coordinately function during vascular development and disease
Blood, January 29, 2009; 113(5): 1184 - 1191.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Biol.Home page
C. Gaitanaki, T. Kalpachidou, I.-K. S. Aggeli, P. Papazafiri, and I. Beis
CoCl2 induces protective events via the p38-MAPK signalling pathway and ANP in the perfused amphibian heart
J. Exp. Biol., July 1, 2007; 210(13): 2267 - 2277.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K.-i. Watanabe, M. Ma, K.-i. Hirabayashi, N. Gurusamy, P. T. Veeraveedu, P. Prakash, S. Zhang, A. J. Muslin, M. Kodama, and Y. Aizawa
Swimming stress in DN 14-3-3 mice triggers maladaptive cardiac remodeling: role of p38 MAPK
Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1269 - H1277.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
W. Ibe, A. Saraste, S. Lindemann, S. Bruder, M. Buerke, H. Darius, K. Pulkki, and L.-M. Voipio-Pulkki
Cardiomyocyte apoptosis is related to left ventricular dysfunction and remodelling in dilated cardiomyopathy, but is not affected by growth hormone treatment
Eur J Heart Fail, February 1, 2007; 9(2): 160 - 167.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
Y.-J. Xu, H. K. Saini, M. Zhang, V. Elimban, and N. S. Dhalla
MAPK activation and apoptotic alterations in hearts subjected to calcium paradox are attenuated by taurine
Cardiovasc Res, October 1, 2006; 72(1): 163 - 174.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
L. Gomez, N. Chavanis, L. Argaud, L. Chalabreysse, O. Gateau-Roesch, J. Ninet, and M. Ovize
Fas-independent mitochondrial damage triggers cardiomyocyte death after ischemia-reperfusion
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2153 - H2158.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
A. Jekell, A. Hossain, U. Alehagen, U. Dahlstrom, and A. Rosen
Elevated circulating levels of thioredoxin and stress in chronic heart failure
Eur J Heart Fail, December 1, 2004; 6(7): 883 - 890.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. Liu, T. Desta, H. He, and D. T. Graves
Diabetes Alters the Response to Bacteria by Enhancing Fibroblast Apoptosis
Endocrinology, June 1, 2004; 145(6): 2997 - 3003.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
H.-R. Liu, L. Tao, E. Gao, B. L Lopez, T. A Christopher, R. N Willette, E. H Ohlstein, T.-L. Yue, and X.-L. Ma
Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion
Cardiovasc Res, April 1, 2004; 62(1): 135 - 144.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. Cornelissen, J. Armstrong, and C. M. Holt
Mechanical Stretch Induces Phosphorylation of p38-MAPK and Apoptosis in Human Saphenous Vein
Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 451 - 456.
[Abstract] [Full Text]

Home page
 J. Appl. Physiol.Home page
Y.-J. Lee, I.-J. Kang, R. Bunger, and Y.-H. Kang
Enhanced survival effect of pyruvate correlates MAPK and NF-{kappa}B activation in hydrogen peroxide-treated human endothelial cells
J Appl Physiol, February 1, 2004; 96(2): 793 - 801.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. Kato, H. Yin, J. Agata, H. Yoshida, L. Chao, and J. Chao
Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1506 - H1514.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
F. Qin, J. Shite, and C.-s. Liang
Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H822 - H832.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Klingel, J.-J. Schnorr, M. Sauter, G. Szalay, and R. Kandolf
{beta}2-Microglobulin-Associated Regulation of Interferon-{gamma} and Virus-Specific Immunoglobulin G Confer Resistance Against the Development of Chronic Coxsackievirus Myocarditis
Am. J. Pathol., May 1, 2003; 162(5): 1709 - 1720.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
G. Valen
The basic biology of apoptosis and its implications for cardiac function and viability
Ann. Thorac. Surg., February 1, 2003; 75(2): S656 - 660.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
L. Hauck, G. Hansmann, R. Dietz, and R. von Harsdorf
Inhibition of Hypoxia-Induced Apoptosis by Modulation of Retinoblastoma Protein-Dependent Signaling in Cardiomyocytes
Circ. Res., November 1, 2002; 91(9): 782 - 789.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
L. Agullo, D. Garcia-Dorado, N. Escalona, J. Inserte, M. Ruiz-Meana, J. A. Barrabes, M. Mirabet, P. Pina, and J. Soler-Soler
Hypoxia and acidosis impair cGMP synthesis in microvascular coronary endothelial cells
Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H917 - H925.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
T. Aoyama, G. Takemura, R. Maruyama, K.-i. Kosai, T. Takahashi, M. Koda, K. Hayakawa, Y. Kawase, S. Minatoguchi, and H. Fujiwara
Molecular mechanisms of non-apoptosis by Fas stimulation alone versus apoptosis with an additional actinomycin D in cultured cardiomyocytes
Cardiovasc Res, September 1, 2002; 55(4): 787 - 798.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. P. Regan, W. Li, D. M. Boucher, S. Spatz, M. S. Su, and K. Kuida
Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects
PNAS, July 9, 2002; 99(14): 9248 - 9253.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
Y. Liu and W. Min
Thioredoxin Promotes ASK1 Ubiquitination and Degradation to Inhibit ASK1-Mediated Apoptosis in a Redox Activity-Independent Manner
Circ. Res., June 28, 2002; 90(12): 1259 - 1266.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
L. Cai, W. Li, G. Wang, L. Guo, Y. Jiang, and Y. J. Kang
Hyperglycemia-Induced Apoptosis in Mouse Myocardium: Mitochondrial Cytochrome c-Mediated Caspase-3 Activation Pathway
Diabetes, June 1, 2002; 51(6): 1938 - 1948.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
G. Yaniv, M. Shilkrut, R. Lotan, G. Berke, S. Larisch, and O. Binah
Hypoxia predisposes neonatal rat ventricular myocytes to apoptosis induced by activation of the Fas (CD95/Apo-1) receptor: Fas activation and apoptosis in hypoxic myocytes
Cardiovasc Res, June 1, 2002; 54(3): 611 - 623.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
F. Qin, N. K. Rounds, W. Mao, K. Kawai, and C.-s. Liang
Antioxidant vitamins prevent cardiomyocyte apoptosis produced by norepinephrine infusion in ferrets
Cardiovasc Res, September 1, 2001; 51(4): 736 - 748.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
Y. Kamogawa, S. Biro, M. Maeda, M. Setoguchi, T. Hirakawa, H. Yoshida, and C. Tei
Dystrophin-deficient myocardium is vulnerable to pressure overload in vivo
Cardiovasc Res, June 1, 2001; 50(3): 509 - 515.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
D B. Sanders, D. F Larson, K. Hunter, M. Gorman, and B. Yang
Comparison of tumor necrosis factor-effect on the expression of iNOS in macrophage and cardiac myocytes
Perfusion, January 1, 2001; 16(1): 67 - 74.
[Abstract] [PDF]

Home page
 Cardiovasc ResHome page
M. Borgers, L.-M. Voipio-Pulkki, and S. Izumo
Apoptosis
Cardiovasc Res, February 1, 2000; 45(3): 525 - 527.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.